Brind.
  1. Pacific Biosciences (PacBio) shares plunged on August 9, 2025, while the S&P 500 increased. The company faced headwinds regarding Americas revenue and was discussing Revio and Vega placements.

MBRU is an early customer of PacBio's Revio technology, with Christian Henry serving as CEO of PacBio.

1 report, 1 independent Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

MBRU is an early customer of PacBio's Revio technology, with Christian Henry serving as CEO of PacBio.

Who's involved

What this event is mainly about
Pacific BiosciencesMohammed Bin Rashid University of Medicine and Health Sciences

Keep exploring

Part of

Pacific Biosciences (PacBio) shares plunged on August 9, 2025, while the S&P 500 increased. The company faced headwinds regarding Americas revenue and was discussing Revio and Vega placements. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswirePacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications Study reveals millions of previously unknown variants and genomic sequences from underrepresented populati